[{"NetIncomeLoss_1_Q2_USD":-75970000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":16826000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":68421086.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":69745297.0,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_2_Q2_USD":-2.17,"IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_1_Q2_USD":-1.09,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":9706000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":1575000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":1117000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-46000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":65829000.0,"PaymentsToAcquireInvestments_2_Q2_USD":370690000.0,"WeightedAverageNumberOfSharesIssuedBasic_2_Q2_shares":69792730.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q2_shares":71094199.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":6101000.0,"AssetsCurrent_0_Q2_USD":745954000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":15339497.0,"AvailableForSaleSecurities_0_Q2_USD":805108000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":5908000.0,"CommonStockSharesIssued_0_Q2_shares":71374059.0,"Assets_0_Q2_USD":898773000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-44000.0,"ShareBasedCompensation_2_Q2_USD":26128000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":36137000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":220235000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":32647000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"DepreciationAndAmortization_2_Q2_USD":1620000.0,"DeferredRevenueRevenueRecognized1_2_Q2_USD":18922000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2233000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-471000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":135158000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":68771000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":68755000.0,"CommonStockValue_0_Q2_USD":7000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":84096000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":96000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":224351000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AvailableForSaleSecuritiesCurrent_0_Q2_USD":400530000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-148653000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-76014000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-3569000.0,"OtherAssetsNoncurrent_0_Q2_USD":5775000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":320482000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":49741000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":438733000.0,"Liabilities_0_Q2_USD":294218000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":4122000.0,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":163000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-2000.0,"RevenueFromRelatedParties_2_Q2_USD":15422000.0,"RevenueFromRelatedParties_1_Q2_USD":7711000.0,"OperatingLeaseLiability_0_Q2_USD":52200000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":805154000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"DeferredRevenueRevenueRecognized1_1_Q2_USD":9461000.0,"InterestReceivableCurrent_0_Q2_USD":1400000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":16577000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":6302000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-476747000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":149869000.0,"CommonStockSharesOutstanding_0_Q2_shares":71374059.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"RestrictedCashNoncurrent_0_Q2_USD":3005000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-90000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-44000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":13367000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-140311000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":5722000.0,"LiabilitiesCurrent_0_Q2_USD":130370000.0,"AccountsPayableCurrent_0_Q2_USD":16957000.0,"NonoperatingIncomeExpense_2_Q2_USD":320000.0,"NonoperatingIncomeExpense_1_Q2_USD":166000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":526000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":21967000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":320482000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.052,"SecurityDeposit_0_Q2_USD":3000000.0,"ShortTermLeaseCost_2_Q2_USD":300000.0,"ShortTermLeaseCost_1_Q2_USD":100000.0,"AdditionalPaidInCapital_0_Q2_USD":1081341000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":323487000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1394000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":6488000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":23806000.0,"NetIncomeLoss_2_Q2_USD":-148563000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q2_USD":1324000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-1412000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":9714000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":103908000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":9086000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":18922000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":9461000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_Q2_shares":1371644.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q2_shares":1348902.0,"OperatingIncomeLoss_2_Q2_USD":-148883000.0,"OperatingIncomeLoss_1_Q2_USD":-76136000.0,"AvailableForSaleSecuritiesNoncurrent_0_Q2_USD":84096000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":50000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":74571000.0,"PreferredStockValue_0_Q2_USD":0.0,"OperatingLeaseCost_2_Q2_USD":2600000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-18922000.0,"OperatingLeaseCost_1_Q2_USD":1500000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":8599000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":26128000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":13367000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2500000.0,"OperatingExpenses_2_Q2_USD":167805000.0,"OperatingExpenses_1_Q2_USD":85597000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":24473000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.17,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.09,"ProfitLoss_2_Q2_USD":-148563000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":10199000.0,"OtherLiabilitiesCurrent_0_Q2_USD":380000.0,"StockholdersEquity_0_Q2_USD":604555000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":898773000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":756000.0,"Ticker":"RCUS","CIK":"1724521","name":"ARCUS BIOSCIENCES, INC.","OfficialName":"Arcus Biosciences Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2226368293.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20210805"}]